MYC and neoplasm: All six lines from resistant tumours were less sensitive to RMC-7977 than a control KPC cell line (K8484) derived from a treatment-naive KPC tumour and confirmed not to have a gain at the Myc locus (Myc stable) (Fig. 6c).